azasetron

This page covers all azasetron drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 3A.

Targets

5-hydroxytryptamine receptor 3A

Phase 2 pipeline (1)

• Nazasetron · Other
  Nazasetron works by binding to the 5-hydroxytryptamine receptor 3A, blocking its action and reducing symptoms.